Results 241 to 250 of about 1,471,752 (332)

Livestock and water in developing countries [PDF]

, 2020
Ericksen, Polly J., Gettel, Gretchen, Muhadia, Collins   +2 more
core  

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Prioritizing Pharmaceuticals for Environmental Monitoring in Greece: A Comprehensive Review of Consumption, Occurrence, and Ecological Risk. [PDF]

Toxics
Chatzipanagiotou KR, Bon A, Petrakli F, Antonaropoulos G, Koumoulos EP.   +4 more
europepmc   +1 more source

Combining the analytical hierarchy process, fuzzy expert systems, and the exponential risk priority number for the holistic evaluation of innovation projects in manufacturing

Quirin Gärtner, Alessandro Bianchi, Harsh Mulrav, Günther Reinhart   +3 more
openalex   +1 more source

Operational programme for human resource development in the Czech Republic [PDF]

, 2001
-
core  

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

AMR surveillance in Canada: Insights from the 2025 Priority Pathogen List. [PDF]

PLoS One
Abdesselam K, Muchaal PK, Mishra A, Ngendabanka RJ, Amaratunga K, Mittal S, Rudnick W, Crago AL, Mitchell R, Alexandre S, Lary T.   +10 more
europepmc   +1 more source

Assessment of Health Problems and Hazards Prevalent among Garment Workers in a Developing Country: An Approach using Risk Priority Number and Best-Worst Method

Farzana Islam
openalex   +2 more sources

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen, Wenting Huang, Yitian Liu, Xuan Chen, Buyu Ke, Qian Shen, Hanyu Cai, Jing Sun, Yan Li, Yungang Cao, Beilei Hu, Keyang Chen   +11 more
wiley   +1 more source

A multi-database pharmacovigilance study reveals distinctive immunosuppressive and opportunistic infection disproportionality signals with bevacizumab and temozolomide combination therapy in glioblastoma. [PDF]

Front Med (Lausanne)
Yu Y, Hou X, Xu K.
europepmc   +1 more source